PHGE - BiomX Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
205.52M
Enterprise Value 3
-20.07M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
1.23

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 324.80%
52 Week High 311.90
52 Week Low 36.13
50-Day Moving Average 39.35
200-Day Moving Average 39.62

Share Statistics

Avg Vol (3 month) 313.34k
Avg Vol (10 day) 311.91k
Shares Outstanding 522.84M
Float 604.37k
% Held by Insiders 118.33%
% Held by Institutions 135.11%
Shares Short (Dec 30, 2019) 438.64k
Short Ratio (Dec 30, 2019) 44.42
Short % of Float (Dec 30, 2019) 40.64%
Short % of Shares Outstanding (Dec 30, 2019) 40.17%
Shares Short (prior month Nov 28, 2019) 424.07k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.29M
Net Income Avi to Common (ttm)-17.93M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)30.01M
Total Cash Per Share (mrq)30.88
Total Debt (mrq)1.13M
Total Debt/Equity (mrq)3.30
Current Ratio (mrq)18.34
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-14M
Levered Free Cash Flow (ttm)N/A